Activation of NK cell-mediated protective immunity for the systemic treatment of ALD
激活 NK 细胞介导的保护性免疫以全身治疗 ALD
基本信息
- 批准号:10453261
- 负责人:
- 金额:$ 43.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-11 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcuteAlcohol consumptionAlcoholic Liver DiseasesAlcoholismAlcoholsAntibodiesAntibody TherapyAutomobile DrivingBlocking AntibodiesCell-Mediated CytolysisCellsCessation of lifeChronicCirrhosisClinical TrialsCombined Modality TherapyDataDetectionDevelopmentDiseaseDisease ProgressionEconomicsEngineeringEventFCGR3B geneFDA approvedFc ReceptorFibrosisFoundationsGoalsHepatic Stellate CellImmuneImmune EvasionImmune responseImmunityImmunologic SurveillanceImmunosuppressionImmunotherapyIn VitroInfiltrationInnate Immune SystemKupffer CellsLinkLiverLiver FailureLiver FibrosisLymphocyteMacrophageMediatingNK Cell ActivationNatural Killer CellsOutcomePathogenicityPatientsPlayPluripotent Stem CellsPublic HealthQuality of lifeResearch ProposalsResistanceResolutionRisk FactorsRoleSeriesShapesSignal TransductionTestingTherapeuticTranslatingTranslationsTreatment EfficacyUnited Statesadverse outcomeantibody testbench to bedsidecellular engineeringcytotoxicdesigneffective therapyefficacy evaluationefficacy testingfibrogenesisimmune cell infiltrateimmune checkpoint blockadeimprovedin vivoinduced pluripotent stem cellinsightliver functionliver injurymanufacturemonocytemouse modelpreclinical studyprogramsresistance mechanismrestorationtreatment responsetreatment strategy
项目摘要
Summary
Chronic and acute (binge) alcohol drinking are major public health and economic problems
worldwide and prominent risk factors for the development of alcoholic liver disease (ALD), a
lethal and incurable condition. Currently there are no FDA-approved therapies for any stage of
ALD, underscoring the urgent need for the approval of new treatments.
The activation of hepatic stellate cells (HSC) and liver-resident macrophages (Kupffer cells, KC)
represent key initiating events in ALD and are central to the onset of fibrosis and liver injury that
results in cirrhosis and liver failure. Fully activated HSC, which emerge pathogenically in the
liver following chronic heavy alcohol consumption, evade immune attack by natural killer (NK)
cells, driving fibrogenesis and liver injury.
Here, we seek to determine whether blockade of NK inhibitory checkpoints can overcome
immune evasion by fully activated HSC. We will also test antibody-directed cellular cytotoxicity
(ADCC) as an approach to trigger NK attack and elimination of activated KC and infiltrating Ly-
6C+ monocyte-derived macrophages, which constitute a parallel fibrogenic hub in ALD, both as
a monotherapy and in combination with NK checkpoint blockade. Finally, we interrogate
whether NK cells manufactured from inducible pluripotent stem cells (iNK), and engineered to
express a chimeric CD16 antibody receptor designed to prime and sensitize NK cytolytic attack,
can potentiate the therapeutic efficacy of ADCC.
These studies will illuminate mechanisms of immune evasion in ALD, and establish NK
checkpoint blockade, ADCC and engineered iNK cells as potentially breakthrough therapeutic
strategies, bringing ALD into the list of diseases that benefit from the revolutionary power of
immunotherapy. Insights gained from these studies can be directly translated from bench to
bedside into clinical trials, leading to direct patient benefit.
摘要
慢性和急性(酗酒)是主要的公共健康和经济问题
酒精性肝病(ALD)发展的世界性和突出的危险因素,
致命的不治之症。目前还没有FDA批准的任何阶段的治疗方法
ALD,强调迫切需要批准新的治疗方法。
肝星状细胞(HSC)和驻肝巨噬细胞(Kupffer cell,KC)的激活
代表ALD中的关键启动事件,是肝纤维化和肝损伤发生的核心
导致肝硬变和肝功能衰竭。完全激活的HSC,在病理性地出现在
长期大量饮酒后的肝脏,逃避自然杀手(NK)的免疫攻击
细胞,导致肝纤维化和肝损伤。
在这里,我们试图确定NK抑制检查点的封锁是否可以克服
完全激活的HSC的免疫逃逸。我们还将测试抗体导向的细胞毒性。
(ADCC)作为一种触发NK攻击和消除激活的KC和浸润性Ly-
6C+单核细胞来源的巨噬细胞,它们构成了ALD中平行的纤维化中心,两者都是
单一疗法,并联合NK检查站封锁。最后,我们审问
NK细胞是否由可诱导的多能干细胞(墨水)制造,并经工程处理以
表达一种嵌合的CD16抗体受体,旨在启动和敏化NK细胞溶解攻击,
可增强ADCC的治疗效果。
这些研究将阐明ALD的免疫逃逸机制,并建立NK
检查点封锁、ADCC和工程墨水细胞作为潜在的突破性治疗
战略,将阿尔茨海默病列入受益于
免疫疗法。从这些研究中获得的见解可以直接从BASE转化为
在床边进行临床试验,直接造福于患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOUGLAS Edmund FELDMAN其他文献
DOUGLAS Edmund FELDMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOUGLAS Edmund FELDMAN', 18)}}的其他基金
Engineering CAR-T for treatment of alcoholic liver disease
用于治疗酒精性肝病的工程 CAR-T
- 批准号:
9894488 - 财政年份:2019
- 资助金额:
$ 43.52万 - 项目类别:
Engineering CAR-T for treatment of alcoholic liver disease
用于治疗酒精性肝病的工程 CAR-T
- 批准号:
10019444 - 财政年份:2019
- 资助金额:
$ 43.52万 - 项目类别:
相似海外基金
The Causal Role of Acute Alcohol Consumption in Risky Sex among HIV-Positive MSM
HIV 阳性 MSM 中急性饮酒与危险性行为的因果关系
- 批准号:
8515264 - 财政年份:2012
- 资助金额:
$ 43.52万 - 项目类别:
The Causal Role of Acute Alcohol Consumption in Risky Sex among HIV-Positive MSM
HIV 阳性 MSM 中急性饮酒与危险性行为的因果关系
- 批准号:
8139578 - 财政年份:2012
- 资助金额:
$ 43.52万 - 项目类别:
The Causal Role of Acute Alcohol Consumption in Unprotected Sex among MSM at Risk for Acquiring HIV
有感染艾滋病毒风险的男男性行为者中急性饮酒与无保护性行为的因果关系
- 批准号:
241812 - 财政年份:2011
- 资助金额:
$ 43.52万 - 项目类别:
Salary Programs
The Causal Role of Acute Alcohol Consumption in Unprotected Sex among MSM at Risk for Acquiring HIV
有感染艾滋病毒风险的男男性行为者中急性饮酒与无保护性行为的因果关系
- 批准号:
215224 - 财政年份:2010
- 资助金额:
$ 43.52万 - 项目类别:
Operating Grants
ESR: CARDIAC ISCHEMIA/REPERFUSION, CHRONIC AND ACUTE ALCOHOL CONSUMPTION
ESR:心脏缺血/再灌注、慢性和急性饮酒
- 批准号:
3931638 - 财政年份:
- 资助金额:
$ 43.52万 - 项目类别:
ELECTROPHYSIOLOGICAL STUDIES OF ACUTE AND CHRONIC ALCOHOL CONSUMPTION
急性和慢性饮酒的电生理学研究
- 批准号:
3789526 - 财政年份:
- 资助金额:
$ 43.52万 - 项目类别:
ELECTROPHYSIOLOGICAL STUDIES OF ACUTE AND CHRONIC ALCOHOL CONSUMPTION
急性和慢性饮酒的电生理学研究
- 批准号:
3767570 - 财政年份:
- 资助金额:
$ 43.52万 - 项目类别:
ELECTROPHYSIOLOGICAL STUDIES OF ACUTE AND CHRONIC ALCOHOL CONSUMPTION
急性和慢性饮酒的电生理学研究
- 批准号:
3817401 - 财政年份:
- 资助金额:
$ 43.52万 - 项目类别:
ELECTROPHYSIOLOGICAL STUDIES OF ACUTE AND CHRONIC ALCOHOL CONSUMPTION
急性和慢性饮酒的电生理学研究
- 批准号:
3745232 - 财政年份:
- 资助金额:
$ 43.52万 - 项目类别:
ELECTROPHYSIOLOGICAL STUDIES OF ACUTE AND CHRONIC ALCOHOL CONSUMPTION
急性和慢性饮酒的电生理学研究
- 批准号:
3808652 - 财政年份:
- 资助金额:
$ 43.52万 - 项目类别: